对于住院老年患者的功能性结果的多组件干预:系统性审查和元分析
Xiaonan Hao1, Yuhang Yang1, Yan Gu2
1School of Nursing, Jilin University, Changchun, Jilin, China.
Journal of the American Medical Directors Association
|November 7, 2025
概括
多组件干预可以改善住院老年人的功能. 关键要素包括体力活动,营养和认知刺激,在出院后的持续效益.
科学领域:
- 老年学是一门学科.
- 康复医学 康复医学 康复医学
- 临床老年病学 临床老年病学
背景情况:
- 住院相关残疾 (HAD) 对老年人来说是一个日益关注的问题.
- 多组件干预是缓解HAD的一个有希望的策略.
研究的目的:
- 评估多组分干预措施对住院老年患者功能结果的疗效.
- 确定关键的干预组件,以提高有效性.
主要方法:
- 12项随机对照试验 (2202名参与者) 的系统综述和元分析.
- 干预措施针对至少两个可修改的HAD风险因素.
- 结果包括ADL,IADL,SPPB,步行速度和握力.
主要成果:
- 在住院期间启动并在出院后持续3个月的干预措施显著改善了ADL (SMD,0.41).
- 在IADLs (SMD,0.36) 和步行速度 (SMD,0.33) 中观察到好处.
- 骨折手术的患者在SPPB得分 (SMD,2.57) 和握力 (SMD,1.98) 中显著改善.
结论:
- 多组件干预措施显示出在住院老年人中功能改善的潜力.
- 优化干预组件和时间对于未来的HAD计划至关重要.
- 由于证据的确定性有限,需要进一步进行高质量的研究.
相关概念视频
Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
Drug Dosing: Geriatric Patients
215
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
215
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
188
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
188
Heart Failure VII: Nursing Interventions
404
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
404
Heart Failure VI: Adjunct Therapies
243
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
243
Nursing Interventions II: Selecting and Classifying the Nursing Interventions
3.0K
Creating and executing a nursing diagnosis helps nurses plan care and guide patient, family, and community interventions. They are developed based on a patient's physical evaluation and support measuring the outcomes. It is not recommended to select random interventions throughout the planning process. Instead, consider the following six essential factors when choosing interventions:
3.0K
